期刊名称：International Journal of Health Policy and Management
电子版ISSN：2322-5939
出版年度：2020
卷号：9
期号：6
页码：229-232
DOI：10.15171/ijhpm.2019.135
出版社：Kerman University of Medical Sciences
摘要：Chronic hepatitis C virus (HCV) infection, associated with severe liver disease and cancer, affects 70 million people worldwide. New treatments with direct-acting-antivirals offer cure for about 95% of affected individuals; however, treatment costs may be prohibitive in both the poorest and richest nations. Opting for cure may require sacrificing essential household assets. We highlight the financial dilemmas involved, drawing parallels between Ethiopia and the United States, countries where universal health coverage does not yet exist. The World Health Organization (WHO) declaration for HCV eradication by 2030 will only become reality if universal access to efficacious and affordable treatment is guaranteed for everyone.
